Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP4K4 | O95819 | 1/20 | 0.40 |
| ▸ | FEN1 | P39748 | 7/20 | 0.40 |
| ▸ | ALOX5AP | P20292 | 5/20 | 0.40 |
| ▸ | BACE1 | P56817 | 1/20 | 0.39 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.39 |
| ▸ | CDC7 | O00311 | 1/20 | 0.39 |
| ▸ | PTPRC | P08575 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.37 |
| ▸ | KDM1A | O60341 | 3/20 | 0.37 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | PLAU | P00749 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1936004 | 1.00 | MAP4K4 (0.40) | MAP4K4FEN1ALOX5APBACE1TGFBR1 | |
| SCHEMBL1935089 | 0.84 | SCN9A (0.46) | FEN1ALOX5APKDM1ATRPA1 | |
| SCHEMBL12439814 | 0.84 | SCN9A (0.46) | FEN1ALOX5APKDM1ATRPA1 | |
| SCHEMBL15237942 | 0.82 | LCK (0.40) | FEN1ALOX5APBACE1TGFBR1KDM1A | |
| SCHEMBL1935139 | 0.82 | LCK (0.40) | FEN1ALOX5APBACE1TGFBR1KDM1A | |
| SCHEMBL12439835 | 0.82 | LCK (0.40) | FEN1ALOX5APBACE1TGFBR1KDM1A | |
| SCHEMBL1934839 | 0.81 | SCN9A (0.48) | FEN1ALOX5APBACE1TGFBR1TRPA1 | |
| SCHEMBL12439746 | 0.81 | SCN9A (0.48) | FEN1ALOX5APBACE1TGFBR1TRPA1 | |
| SCHEMBL12439757 | 0.81 | SLC9A1 (0.40) | BACE1TGFBR1PLAU | |
| SCHEMBL1934808 | 0.79 | SCN9A (0.52) | FEN1ALOX5APTRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2332936-B1 | PYRIDINE COMPOUND AND USE THEREOF FOR PEST CONTROL | SUMITOMO CHEMICAL CO (JP) | 2013-09-04 | — | — | EP | disclosed |
| US-20110178132-A1 | PYRIDINE COMPOUND AND USE THEREOF FOR PEST CONTROL | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2011-07-21 | — | — | US | disclosed |
| US-20110178132-A1 | PYRIDINE COMPOUND AND USE THEREOF FOR PEST CONTROL | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2011-07-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110178132-A1 | PYRIDINE COMPOUND AND USE THEREOF FOR PEST CONTROL | C5, PRDX1, PRDX4 | MAP4K4 1628/4885FEN1 3369/4885ALOX5AP 579/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.